Multicenter, randomized, double blind, placebo-controlled trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pulmonary hypertension due to parenchymal lung disease
This study is evaluating the effect of an experimental drug in patients with pulmonary hypertension due to parenchymal lung disease.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005